Skip to search formSkip to main contentSkip to account menu

CGS 26303

Known as: CGS-26303, Phosphonic acid, (((2-(1,1'-biphenyl)-4-yl-1-(1H-tetrazol-5-yl)ethyl)amino)methyl)-, (S)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Endothelin-1 (ET-1) has been implicated in many neurological diseases, including subarachnoid hemorrhage (SAH) and cerebral… 
2004
2004
Endothelin-1 has been shown to aggravate the ischemicreperfusion injury in the neocortex of rats. The purpose of this study was… 
2002
2002
Increasing evidence has implicated endothelin-1 (ET-1), a potent vasoconstrictive peptide, in the pathophysiology of cerebral… 
2000
2000
BACKGROUND/PURPOSE The pathophysiology of congenital diaphragmatic hernia (CDH) associated with lung hypoplasia and pulmonary… 
1999
1999
Endothelins (ETs), potent vasoactive peptides, are present in many ocular tissues including the ciliary epithelium where active… 
1999
1999
Emerging evidence supports a mediator role for endothelin (ET)-1 in airway diseases including asthma. Respiratory tract viral… 
1998
1998
The effect of CGS 26303, an endothelin-converting enzyme inhibitor, on the prevention and reversal of cerebral vasospasm was… 
1997
1997
Abstract Treatment of animals with big endothelin-1 (bET) causes pulmonary hypertension and bronchoconstriction, both in vivo and…